Emil Kongsø-Larsen

Equibles does not estimate personal net worth.

Get an email with a short summary when Novo Nordisk A S publishes a filing, an earnings call transcript or a press release.

Get NVO alerts

About Emil Kongsø-Larsen

Emil Kongsø-Larsen has spoken on 1 earnings call across 1 company, most recently for Novo Nordisk A S on November 4, 2026. Novo Nordisk A S is classified in the Drug Manufacturers - General industry within the Healthcare sector.

Emil Kongsø-Larsen on recent calls

“Growth in I.O. continued to be driven by our GLP-1 portfolio in the third quarter. The total GLP-1 sales increasing by 8%. Obesity remains the key growth driver, delivering 24% growth, supported by continued volume uptake of Vigovi across regions.”

Other, Third quarter · November 4, 2026